The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation
Many polyphenolic compounds have been reported to inhibit protein kinases, with special reference to CK2, a pleiotropic serine/threonine kinase, implicated in neoplasia, neurodegenerative disease, and viral infections. In general however these compounds are not endowed with stringent selectivity. Am...
Main Authors: | Giorgio Cozza, Andrea Venerando, Stefania Sarno, Lorenzo A. Pinna |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/734127 |
Similar Items
-
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
by: Giorgio Cozza
Published: (2017-02-01) -
Spectrophotometric Determination of Microgram Amounts of Aliphatic Amines with Quinalizarin
by: T. Al-Ghabsha, et al.
Published: (2009-03-01) -
Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin
by: Monica Força Lima, et al.
Published: (2017-07-01) -
The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.
by: Jordi Vilardell, et al.
Published: (2018-01-01) -
Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.
by: Andrea Venerando, et al.
Published: (2013-01-01)